Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Pediatric Patients with Narcolepsy
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Pediatric Patients with Narcolepsy
PH Management Into the Future: Understanding the Next Generation of Treatments and Mechanisms
PH Management Into the Future: Understanding the Next Generation of Treatments and Mechanisms
Current Pharmacologic Approaches to Managing Pediatric Narcolepsy
Current Pharmacologic Approaches to Managing Pediatric Narcolepsy
Can We Talk? Optimizing Patient and Parent/Caregiver Buy-in to the Management of Pediatric Narcolepsy
Can We Talk? Optimizing Patient and Parent/Caregiver Buy-in to the Management of Pediatric Narcolepsy
Evolving Therapy for Managing Pediatric Narcolepsy: Wake-Promoting Pitolisant
Evolving Therapy for Managing Pediatric Narcolepsy: Wake-Promoting Pitolisant
Key Differences Among the Clinical Manifestations of Narcolepsy Symptoms in Children Versus Adults
Key Differences Among the Clinical Manifestations of Narcolepsy Symptoms in Children Versus Adults
Don’t Wait to Escalate—Getting Aggressive in PH Management
Don’t Wait to Escalate—Getting Aggressive in PH Management
Practical Implications of New Treatments in Clinical Practice
Practical Implications of New Treatments in Clinical Practice
Evolving Therapy for Managing Pediatric Narcolepsy: Once-Nightly Sodium Oxybate
Evolving Therapy for Managing Pediatric Narcolepsy: Once-Nightly Sodium Oxybate
Narcolepsy’s Burden of Illness: It’s Impact on the Child and Family
Narcolepsy’s Burden of Illness: It’s Impact on the Child and Family
Managing Treatment-Related Toxicities With JAK Inhibitor Therapy in Myelofibrosis
Managing Treatment-Related Toxicities With JAK Inhibitor Therapy in Myelofibrosis
Real-World Experience With Pacritinib in the US
Real-World Experience With Pacritinib in the US
Improving Transfusion Independence With JAK Inhibitor Therapy
Improving Transfusion Independence With JAK Inhibitor Therapy
